Back
AbCellera Biologics Vs. Dyne Therapeutics Industry Stock Comparison
Sell
33
ABCL
AbCellera Biologics
Last Price:
2.89
Seasonality Move:
-14.41%
Buy
64
DYN
Dyne Therapeutics
Last Price:
35.41
Seasonality Move:
29.58%
Sell
33
AbCellera Biologics (ABCL)
is a Sell
Is AbCellera Biologics a Buy, Sell or Hold?
- The current AbCellera Biologics [ABCL] share price is $2.79. The Score for ABCL is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- ABCL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Dyne Therapeutics (DYN)
is a Buy
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $33.92. The Score for DYN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ABCL Stock Price Chart
What is AbCellera Biologics's stock price today?
-
The AbCellera Biologics share price today is $2.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABCL is experiencing slight selling pressure.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $33.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.
ABCL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 20.9 | Sell |
Chaikin Money Flow: | -599051 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.06 - 3.94) | Sell |
Bollinger Bands (100): | (3.59 - 4.89) | Sell |
DYN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.3 | Buy |
Relative Strength Index (14 RSI): | 57.37 | Buy |
Chaikin Money Flow: | 599904 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.98 - 33.66) | Buy |
Bollinger Bands (100): | (23.98 - 30.96) | Buy |
ABCL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.93 | Sell |
20-day SMA: | 3.4 | Sell |
50-day SMA: | 3.68 | Sell |
200-day SMA: | 4.55 | Sell |
8-day EMA: | 2.95 | Sell |
20-day EMA: | 3.26 | Sell |
50-day EMA: | 3.67 | Sell |
200-day EMA: | 4.77 | Sell |
DYN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.61 | Buy |
20-day SMA: | 32.56 | Buy |
50-day SMA: | 29.25 | Buy |
200-day SMA: | 19.48 | Buy |
8-day EMA: | 33.72 | Buy |
20-day EMA: | 32.57 | Buy |
50-day EMA: | 30.2 | Buy |
200-day EMA: | 22.36 | Buy |
AbCellera Biologics Earnings Growth & ABCL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.06 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.77 per share, and an increase next year of $0.16 per share.
AbCellera Biologics Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dyne Therapeutics Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |